Upload
Featured Recent Articles Topics Login Upload

Search Results for 'Rituximab-Cll'

Rituximab-Cll published presentations and documents on DocSlides.

Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
by conchita-marotz
ASH Review 2012. Stephen Spurgeon (spurgeos@ohsu....
Integration of Novel Therapies in WM and CLL : When and How
Integration of Novel Therapies in WM and CLL : When and How
by giovanna-bartolotta
Neil E Kay, M.D.. October 2014. Mayo Team. Deb Bo...
Chronic lymphocytic leukemia,
Chronic lymphocytic leukemia,
by natalia-silvester
New agents timing?. Agne Paner, MD. Assistant pro...
Patients with total IgG <400 mg/dL while receiving rituximab should
Patients with total IgG <400 mg/dL while receiving rituximab should
by ivy
NOT. receive IgG replacement therapy. . AAIFNC F...
Carfilzomib , Rituximab and Dexamethasone (
Carfilzomib , Rituximab and Dexamethasone (
by mindeeli
CaRD. ) Is Highly . Active and . Offers a Neuropat...
Please note, these are the actual video-recorded proceeding
Please note, these are the actual video-recorded proceeding
by luanne-stotts
Moderator. Neil Love, MD. Mollie Moran, MSN, CNP,...
Module 3: Chronic Lymphocytic Leukemia
Module 3: Chronic Lymphocytic Leukemia
by CottonTails
Josie . Montegaard. , MSN, AGPCNP-BC. Matthew S . ...
A Phase 1 Study of the Selective Phosphatidylinositol 3-Kinase-Delta (PI3K
A Phase 1 Study of the Selective Phosphatidylinositol 3-Kinase-Delta (PI3K
by windbey
δ. ) Inhibitor, . Idelalisib. (GS-1101) in Combi...
Update on chronic lymphocytic leukemia (CLL) treatment
Update on chronic lymphocytic leukemia (CLL) treatment
by joy
Dr Mona Yuklea. Hematology Department, Meir Hospi...
Confirmation Hymns reproduced under licence CLL 27398 and Calamus 0269
Confirmation Hymns reproduced under licence CLL 27398 and Calamus 0269
by carny
Mallaig. Sprinkling Song . Spirit of God, come dw...
2022-2023 CLLS Continuing Libraries
2022-2023 CLLS Continuing Libraries
by hazel
Application Information Session. Thursday, April 7...
CLL Stromal cell protect
CLL Stromal cell protect
by tawny-fly
CLL Stromal cell protect Conventional therapies V...
Hull CLLD Grants Community-Led Local Development
Hull CLLD Grants Community-Led Local Development
by celsa-spraggs
Session Agenda. Section 1 . – . CLLD Essentials...
Guidance on CLLD for local
Guidance on CLLD for local
by test
actors. Key messages . Paul Soto. Target:- . pote...
LEADER/CLLD
LEADER/CLLD
by mitsue-stanley
gahering. : Role of . bottom. -up . approach. . ...
Clonal Evolution in CLL:
Clonal Evolution in CLL:
by karlyn-bohler
Impact . on t. iming . of . therapy. Nicholas Chi...
227 EMEA 2005 Since all the treatment regimens used so far have only
227 EMEA 2005 Since all the treatment regimens used so far have only
by priscilla
Zevalin, supplied as kit for radiopharmaceutical p...
rials as treatment options for eligible patients
rials as treatment options for eligible patients
by elysha
Page 1 of 13 Note : Consider C linical T . Wa...
Published in nejm in sep 2016
Published in nejm in sep 2016
by Wildboyz
RITUXIMAB IN B-LINEAGE ADULT ACUTE LYMPHOBLASTIC L...
Future directions: Can we improve outcomes in relapsed/refractory DLBCL or aggressive NHL?
Future directions: Can we improve outcomes in relapsed/refractory DLBCL or aggressive NHL?
by mitsue-stanley
Bertrand Coiffier. Service d. ’. Hématologie. ...
Updates in Lymphoma From Recent Congresses
Updates in Lymphoma From Recent Congresses
by lindy-dunigan
Therapeutic Targets in CLL. Venetoclax in Patient...
Indolent Non-Hodgkin L
Indolent Non-Hodgkin L
by danika-pritchard
ymphoma. Sobia Ozair. March 8, 2017. MD Anderson ...
Emanuele Zucca, MD Oncology Institute of Southern Switzerland (IOSI)
Emanuele Zucca, MD Oncology Institute of Southern Switzerland (IOSI)
by ellena-manuel
Swiss Group for Clinical Cancer Research (SAKK). ...
A Closer Look at Pemphigus Vulgaris: Clinical Challenges and
A Closer Look at Pemphigus Vulgaris: Clinical Challenges and
by celsa-spraggs
Emerging Treatments . Description of Program. Thi...
Update on Follicular Lymphoma:
Update on Follicular Lymphoma:
by tatiana-dople
Contemporary Treatment Strategies and Optimal Seq...
Update on Follicular Lymphoma:
Update on Follicular Lymphoma:
by alexa-scheidler
Contemporary Treatment Strategies and Optimal Seq...
CLL: clinical cases Celso Arrais
CLL: clinical cases Celso Arrais
by genevieve
Conflict of Interests. I declare NO relevant confl...
Research To Practice ASH 2022 CLL Updates
Research To Practice ASH 2022 CLL Updates
by erica
John N. Allan. Associate Professor of Clinical Med...
Dr.V.Shanthi Associate Professor , Pathology
Dr.V.Shanthi Associate Professor , Pathology
by luna
Sri . Venkateswara. Institute of Medical Sciences...
Hima Darapu, MD Princeton Baptist Medical Center
Hima Darapu, MD Princeton Baptist Medical Center
by felicity
Baptist Health systems Alabama. Baseline Flow Cyto...
groupoflymphoidmalignancieswhichshareclinicalandprognosticfeaturesofin
groupoflymphoidmalignancieswhichshareclinicalandprognosticfeaturesofin
by erica
Table1ClinicalandimagingcharacteristicsofBcellindo...
uidelines
uidelines
by stella
Pan - London Haemato - O ncology Clinical G Lymph...
Reproducible diagnosis of
Reproducible diagnosis of
by davis
Title: Chronic Lymphocytic Leukemia by flow cyto...
Chronic Lymphocytic
Chronic Lymphocytic
by caitlin
A Guide for Being diagnosed with Chronic Lymphocy...
PATIENT EDUCATION
PATIENT EDUCATION
by brooke
Introduction Chronic lymphocytic leukemia (CLL) is...
Presenter : CR 周益聖
Presenter : CR 周益聖
by CottonTails
Supervisor: VS . 曾主任. Cell 152, 714–726, F...
Comparison between Time-
Comparison between Time-
by LifeOfTheParty
Limited,Venetoclax. -Based and Continuous Bruton ....
Survival and Clinical Aspects for Patients with Chronic Lymphocytic Leukemia in Kermanshah, Iran
Survival and Clinical Aspects for Patients with Chronic Lymphocytic Leukemia in Kermanshah, Iran
by Tigerwoods
Mehrdad. . Payandeh. Department of Hematology and...
CHARACTERIZATION AND MANAGEMENT OF SYNCHRONOUS DUAL HEMATOLOGICAL MALIGNANCIES
CHARACTERIZATION AND MANAGEMENT OF SYNCHRONOUS DUAL HEMATOLOGICAL MALIGNANCIES
by susan
Rouslan Kotchetkov. ,. MD, PhD. 1. , Erin Ellison...
Using DNA copy number aberrations to
Using DNA copy number aberrations to
by pamela
identify candidate drivers of . carcinogenesis in ...